PATRICIA PANFILE: Open Payments
NPI 1912022898 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 61 payments from 16 companies in 2025. Trend: 2023 $1,387 · 2024 $1,594 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $317 |
| Boston Scientific Corporation | 4 | $162 |
| Actelion Pharmaceuticals US, Inc. | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Imperative Care, Inc | 3 | $70 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| CVRx, Inc. | 2 | $37 |
| ABIOMED | 2 | $28 |
| Philips North America LLC | 1 | $26 |
Products named: LEQVIO, General - CRM_CRM, UPTRAVI, JARDIANCE, LifeVest, WATCHMAN FLX, Barostim Neo System, CAMZYOS.
Industry payments across NJ — which companies pay providers there.
